FDA grants 510(k) clearance for cardiac transducer

The FDA granted a 510(k) clearance to the S4-1 cardiac transducer for Lumify, a smart device powered ultrasound from Royal Philips.

The company announced the clearance in an Oct. 14 news release and at The American College of Emergency Physicians annual meeting in Las Vegas.

Philips said the S4-1 cardiac transducer will allow the Lumify to be used for cardiac imaging. The S4-1 transducer and cable, which weighs 152 grams, is smaller than a smartphone, according to the company.

Philips introduced Lumify in 2015. It is now available for use in ambulatory settings, cardiac and abdominal imaging and OB/GYN and FAST exam pre-sets.

“Lumify is a game-changing innovation,” John Bailitz, MD, and emergency ultrasound physician in Illinois, said in a news release. “The affordability, flexibility and versatility of Lumify make it appealing to those working in emergency settings, and now with the S4-1 cardiac probe and FAST exam pre-sets, we can conduct critical exams at the point-of-care, resulting in more efficient triage of patients.”

Tim Casey,

Executive Editor

Tim Casey joined TriMed Media Group in 2015 as Executive Editor. For the previous four years, he worked as an editor and writer for HMP Communications, primarily focused on covering managed care issues and reporting from medical and health care conferences. He was also a staff reporter at the Sacramento Bee for more than four years covering professional, college and high school sports. He earned his undergraduate degree in psychology from the University of Notre Dame and his MBA degree from Georgetown University.

Around the web

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.